SCHEMBL19904492

SCHEMBL19904492

CC(C)Oc1ccc(CC(CN2CCCC2)NC(=O)[C@@H]2CCN(c3ccc(F)cc3)C2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 11/20 0.43
ACACA Q13085 2/20 0.42
DEGS1 O15121 2/20 0.40
NOTUM Q6P988 1/20 0.39
SSTR1 P30872 2/20 0.38
SSTR3 P32745 2/20 0.38
CYP2D6 P10635 1/20 0.38
DRD2 P14416 1/20 0.38
HTR2C P28335 1/20 0.38
SSTR2 P30874 1/20 0.38
SSTR4 P31391 1/20 0.38
SSTR5 P35346 1/20 0.38
ADRA1A P35348 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRM4 P08173 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904546 1.00 ACACB (0.43) ACACBACACADEGS1NOTUMSSTR1
SCHEMBL19904662 0.92 ACACB (0.43) ACACBACACANOTUMTSHR
SCHEMBL19904433 0.88 GPR119 (0.42) ACACBDEGS1NOTUMSSTR1SSTR3
SCHEMBL16695267 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL16695165 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL19894585 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL29604591 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL18094916 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL16695266 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM
SCHEMBL19894464 0.83 ACACB (0.46) ACACBACACADEGS1NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed